StonvexLoading…
StonvexStonvexStonvexCore line items from OPAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $80.08M | $567.81M | $453.69M | $321.01M |
Operating Income | $-9.03M | $-33.39M | $-26.06M | $-19.32M |
Net Income | $-10.13M | $-46.38M | $-37.56M | $-25.96M |
EPS (Diluted) | $-0.22 | $-1.50 | $-1.30 | $-0.94 |
Total Assets | $149.77M | $154.77M | $223.46M | $267.99M |
Total Liabilities | $103.93M | $116.55M | $183.61M | $243.45M |
Cash & Equivalents | $40.82M | $26.54M | $30.96M | $22.65M |
Free Cash Flow OCF − CapEx | $9.03M | $65.73M | $15.23M | $-24.73M |
Shares Outstanding | 46.19M | 30.99M | 28.89M | 27.67M |